PANGAEA ONCOLOGY
Pangaea Oncology is a Barcelona-based medical services company specializing in precision oncology and personalized medicine through genetic analyses to improve cancer patient survival and quality of life. The company operates two main interrelated divisions: a clinical care division and a state-of-the-art laboratory offering molecular diagnostics, pre-treatment services, and diagnostic consultancy for patients and pharmaceutical companies. Their R&D division focuses on developing diagnostic tools, predictive models in liquid biopsy and massive sequencing, and pre-clinical research tools. Pangaea Oncology aims to be a European reference in precision oncology by integrating disruptive technology, medical-scientific excellence, and intelligent IT systems including AI and big data for data exploitation. Their services include rapid and accurate molecular diagnostics, companion diagnostics platform validation, and pre-clinical services such as biomarker discovery, in-vitro testing, and organoid technology. The company emphasizes integrity, scientific rigor, innovation, commitment, transparency, and diagnostic quality in its mission to change the natural history of cancer.
PANGAEA ONCOLOGY
Pangaea Oncology is a Barcelona-based medical services company specializing in precision oncology and personalized medicine through genetic analyses to improve cancer patient survival and quality of life. The company operates two main interrelated divisions: a clinical care division and a state-of-the-art laboratory offering molecular diagnostics, pre-treatment services, and diagnostic consultancy for patients and pharmaceutical companies. Their R&D division focuses on developing diagnostic tools, predictive models in liquid biopsy and massive sequencing, and pre-clinical research tools. Pangaea Oncology aims to be a European reference in precision oncology by integrating disruptive technology, medical-scientific excellence, and intelligent IT systems including AI and big data for data exploitation. Their services include rapid and accurate molecular diagnostics, companion diagnostics platform validation, and pre-clinical services such as biomarker discovery, in-vitro testing, and organoid technology. The company emphasizes integrity, scientific rigor, innovation, commitment, transparency, and diagnostic quality in its mission to change the natural history of cancer.